Norgestimate And Ethinyl Estradiol Kit
Product Images NDC 68462-565

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 68462-565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blistercard1

Norgestimate and Ethinyl Estradiol Tablets kit showing a 28-day pill tray with four rows labeled Week 1 to Week 4 and columns for days Sunday through Saturday. Blue pills are indicated as active, while light green pills are inactive. The label lists the strength as 0.25 mg/0.035 mg and includes a child safety warning.*

FDA Label Image

Blistercard2

An instructional diagram for Norgestimate and Ethinyl Estradiol tablets, showing a 4-week pill schedule. Each week is organized by day, with color-coded pills: white to off-white, light blue, and blue pills are active; light green pills are inactive. The diagram includes a note about the package not being child resistant and medication safety.*

FDA Label Image

Carton Label

Packaging label for Norgestimate and Ethinyl Estradiol Tablets USP, containing 0.25 mg/0.035 mg strengths. This 28-day regimen kit includes 3 blister cards each with 28 tablets. The label shows Glenmark Pharmaceuticals Inc., USA as the labeler. The carton provides detailed storage information, usage notes, and a note that this product is prescription-only.*

FDA Label Image

Figure 1

A forest plot chart illustrating relevant studies on the risk of breast cancer associated with combined oral contraceptive (COC) use. The chart compares effect estimates for ever COC use vs. never use and current COC use vs. never use, listing specific studies by author and year. Effect estimates with confidence intervals are plotted horizontally along the x-axis labeled 'Effect Estimate', ranging approximately from -1.50 to 2.00.*

FDA Label Image

Figurea

Norgestimate and Ethinyl Estradiol Tablets USP 0.25 mg/0.035 mg packaged in a 28-day oral tablet calendar kit. The kit includes 21 blue active pills and 7 light green inactive pills, arranged in four weekly rows, with days of the week labeled to guide dosing. The labeler is Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Figureb

An illustrated pill pack chart for Norgestimate and Ethinyl Estradiol tablets, showing a 4-week cycle segmented by day of the week (Sunday to Saturday) and week (1 to 4). It indicates four pill types by color: white to off-white, light blue, and blue pills are active, while light green pills are inactive. A caution note about child resistance is included.*

FDA Label Image

Figurec

An instructional diagram showing a finger peeling a circular tablet from a blister pack. The diagram includes arrows labeled "Start" and "Week 2," pointing to tablets under the day labels "SUN" and "MON." This figure (Figure C) illustrates how to remove tablets according to days of the week during usage.*

FDA Label Image

Figured

Instructional illustrations showing how to use blister cards for Norgestimate and Ethinyl Estradiol tablets. Two separate 28-day pill packs are depicted, each marked with days of the week and weeks 1 through 4. A hand is shown peeling back a foil strip to access a tablet, demonstrating the daily oral contraceptive regimen.*

FDA Label Image

Figuree

An instructional line drawing labeled 'Figure E' showing a hand placing a tablet onto a circular daily pill slot in a medication kit. The diagram highlights the 'Start' and 'Week 2' rows beneath days of the week columns, including Sunday and Monday, indicating a dosing schedule for Norgestimate and Ethinyl Estradiol kit.*

FDA Label Image

Figuref

An instructional diagram showing a calendar layout for a weekly pill schedule from Sunday to Monday across four weeks, labeled Start, Week 2, Week 3, and Week 4. The image includes an illustration of a hand holding a pill blister, demonstrating pill removal from the packaging, related to the Norgestimate and Ethinyl Estradiol kit.*

FDA Label Image

Logo (Logo)

FDA Label Image

Carton Label

Norgestimate and Ethinyl Estradiol Tablets USP kit by Glenmark Pharmaceuticals Inc., USA. The label shows three strengths: 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, and 0.25 mg/0.035 mg of norgestimate and ethinyl estradiol. The package contains 3 blister cards, each with 28 tablets, designed for a 28-day regimen. The label includes storage instructions, dosage information, and manufacturer details.*

FDA Label Image

Structures (Chem Structures)

Chemical structure diagram showing Norgestimate, USP and Ethinyl Estradiol, USP, the active ingredients in Norgestimate and Ethinyl Estradiol. Each structure is labeled and depicts the molecular arrangement of atoms and bonds.*

FDA Label Image

Img3 (Img3)

A chart illustrating pregnancy rates per 100 women in one year relative to different birth control methods. The chart is vertically oriented with 'Fewer Pregnancies' at the top and 'More Pregnancies' at the bottom. Methods are categorized by effectiveness: implants, injections, intrauterine devices, and sterilization show the fewest pregnancies; birth control pills, skin patch, and vaginal ring with hormones follow; condoms and diaphragm are listed next; no sex during fertile days, spermicide, and withdrawal have higher pregnancies; and no birth control is associated with the most pregnancies.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.